NHI NATIONAL HEALTH INVESTORS INC Insider Trading

NHI director McCabe buys 890 shares at $71.65; 100% of prior buys well-timed at 90-day mark.

Robert A Jr McCabe, a director of National Health Investors Inc, purchased 890 shares at $71.65 on 2026-06-15, increasing his holdings from 43.3K to 44.2K shares (+2.1%). The stock is currently trading at $70.70, down -22.6% from its 52-week high of $91.38 and down -5.3% over the past 30 days. Across his cross-ticker track record, McCabe has executed 1 prior open-market buy with a 90-day win rate of 100.00%, and his singular prior purchase at NHI on 2024-05-31 posted a +22.2% 90-day return. The company's fundamentals show revenue growth of +12.1% annually and a P/E of 23.10, with latest-quarter revenue of $115.1M and net income of $40.1M. McCabe's historical buy timing at this specific ticker is perfect, though recent price momentum has been negative over both 30 and 90 days.

CEO D. Eric Mendelsohn buys 1,500 shares of NHI at $68.84 on 2026-06-05; stock down 23.6% from 52-week high.

CEO D. Eric Mendelsohn purchased 1,500 shares at $68.84, increasing his holdings from 131.8K shares to 133.3K shares. The purchase occurred when the stock was trading $69.78 (current price), down 17.5% over the prior 90 days and 23.6% below its 52-week high of $91.38. Despite the price decline, the company posted strong recent fundamentals: $115.1M in latest-quarter revenue, $40.1M in net income, and 12.1% annual revenue growth. The open-market buy by the sitting CEO at a depressed price level relative to recent trading range warrants monitoring, particularly given the magnitude of price deterioration in the near-term window.